ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: CML is a clonal myeloproliferative disease [14] characterized by the breakpoint cluster region proto oncogene 1 tyrosine protein kinase (BCR-ABL1) fusion gene, derived from the t(9;22) translocation [15,16,17].